Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

Worldwide, millions of people are worried about increasing heart disease, which encompasses high blood pressure, coronary ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron ...

Breakthrough Cardiac Regeneration Research Offers Hope for the Treatment of Ischemic Heart Failure Mar. 7, 2025 — The discovery of a novel approach to promote cardiomyocyte proliferation offers ...

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...

The decision to move forward with a heart transplant is made when all other treatment options been unsuccessful.

Eli Lilly And Co (NYSE:LLY), on Sunday, announced positive Phase 2 results for lepodisiran, an investigational small ...